Journal of minimally invasive gynecology
-
J Minim Invasive Gynecol · Jul 2005
Randomized Controlled Trial Clinical TrialUse of sublingual buprenorphine for pain relief in office hysteroscopy.
To assess the efficacy of sublingual buprenorphine in the relief of pain associated with office hysteroscopy. ⋯ Office hysteroscopy with a 3.1-mm flexible hysteroscope is a well-tolerated procedure. Sublingual buprenorphine is not helpful in relieving the pain associated with hysteroscopy but is associated with significant adverse reactions.
-
J Minim Invasive Gynecol · Jul 2005
Randomized Controlled Trial Clinical TrialEffect of bupivacaine after operative laparoscopic gynecologic procedures.
To evaluate the effect of intraperitoneal installation and periportal infiltration of bupivacaine on postoperative pain and return of bowel function. ⋯ Intraperitoneal installation and periportal infiltration of bupivacaine decrease postoperative pain and hasten the return of bowel function. Both decreased postoperative pain and shortened duration for the return of bowel function are crucial for comfort and discharge of the patient.
-
J Minim Invasive Gynecol · Jul 2005
Randomized Controlled Trial Clinical TrialPreemptive analgesia installation during gynecologic laparoscopy: a randomized trial.
To evaluate the efficacy of intraoperative infusion of bupivacaine solution for the relief of pain after operative gynecologic laparoscopy. ⋯ Intraperitoneal bupivacaine administration both immediately after placement of trocars and at the end of surgery was found to be effective in reducing the intensity of AVP but not in reducing STP, APP, or postoperative analgesia consumption after nonadvanced gynecologic laparoscopic procedures. The duration of the analgesic effect of bupivacaine instilled into the peritoneal cavity did not exceed 8 hours and probably was not dose related.